These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20482512)

  • 1. Medications acting on the GABA system in the treatment of alcoholic patients.
    Caputo F; Bernardi M
    Curr Pharm Des; 2010; 16(19):2118-25. PubMed ID: 20482512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications.
    Leggio L; Kenna GA; Swift RM
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1106-17. PubMed ID: 18029075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethanol, GABA and epilepsy.
    Brailowsky S; García O
    Arch Med Res; 1999; 30(1):3-9. PubMed ID: 10071417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses.
    Leone MA; Vigna-Taglianti F; Avanzi G; Brambilla R; Faggiano F
    Cochrane Database Syst Rev; 2010 Feb; (2):CD006266. PubMed ID: 20166080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome.
    Busardò FP; Kyriakou C; Napoletano S; Marinelli E; Zaami S
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4654-63. PubMed ID: 26698265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidity.
    Caputo F; Francini S; Brambilla R; Vigna-Taglianti F; Stoppo M; Del Re A; Leggio L; Addolorato G; Zoli G; Bernardi M
    Eur Neuropsychopharmacol; 2011 Jun; 21(6):450-6. PubMed ID: 21276717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel anticonvulsants in the treatment of alcoholism.
    Book SW; Myrick H
    Expert Opin Investig Drugs; 2005 Apr; 14(4):371-6. PubMed ID: 15882114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABA systems, benzodiazepines, and substance dependence.
    Malcolm RJ
    J Clin Psychiatry; 2003; 64 Suppl 3():36-40. PubMed ID: 12662132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm.
    Myrick H; Anton R; Voronin K; Wang W; Henderson S
    Alcohol Clin Exp Res; 2007 Feb; 31(2):221-7. PubMed ID: 17250613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma-aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability, and treatment.
    Krystal JH; Staley J; Mason G; Petrakis IL; Kaufman J; Harris RA; Gelernter J; Lappalainen J
    Arch Gen Psychiatry; 2006 Sep; 63(9):957-68. PubMed ID: 16952998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABAergic mechanisms in alcohol dependence.
    Uusi-Oukari M; Korpi ER
    Int Rev Neurobiol; 2024; 175():75-123. PubMed ID: 38555121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manipulation of GABAergic steroids: Sex differences in the effects on alcohol drinking- and withdrawal-related behaviors.
    Finn DA; Beckley EH; Kaufman KR; Ford MM
    Horm Behav; 2010 Jan; 57(1):12-22. PubMed ID: 19615369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin for the treatment of alcohol use disorder.
    Mason BJ; Quello S; Shadan F
    Expert Opin Investig Drugs; 2018 Jan; 27(1):113-124. PubMed ID: 29241365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Gabapentin on Dorsal Anterior Cingulate Cortex GABA and Glutamate Levels and Their Associations With Abstinence in Alcohol Use Disorder: A Randomized Clinical Trial.
    Prisciandaro JJ; Hoffman M; Brown TR; Voronin K; Book S; Bristol E; Anton RF
    Am J Psychiatry; 2021 Sep; 178(9):829-837. PubMed ID: 34256607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of alcohol withdrawal syndromes - Recommendations of the Polish Psychiatric Association and the Pharmacotherapy Section of the Polish Society for Addiction Research.
    Mierzejewski P; Bieńkowski P; Jakubczyk A; Samochowiec J; Silczuk A; Wojnar M
    Psychiatr Pol; 2022 Jun; 56(3):433-452. PubMed ID: 36342978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized placebo-controlled trial.
    Förg A; Hein J; Volkmar K; Winter M; Richter C; Heinz A; Müller CA
    Alcohol Alcohol; 2012; 47(2):149-55. PubMed ID: 22215002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of baclofen in the treatment of alcohol-dependent patients.
    Addolorato G; Leggio L
    Curr Pharm Des; 2010; 16(19):2113-7. PubMed ID: 20482507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for valproate in the treatment of sedative-hypnotic withdrawal and for relapse prevention.
    Harris JT; Roache JD; Thornton JE
    Alcohol Alcohol; 2000; 35(4):319-23. PubMed ID: 10905994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
    Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive performance, alcohol withdrawal, and effects of a combination of flumazenil and gabapentin in alcohol dependence.
    Schacht JP; Randall PK; Waid LR; Baros AM; Latham PK; Wright TM; Myrick H; Anton RF
    Alcohol Clin Exp Res; 2011 Nov; 35(11):2030-8. PubMed ID: 21631542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.